Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Author:
Funder
NIH
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference277 articles.
1. Beyond chemotherapy: targeted therapies in ovarian cancer;Yap;Nat. Rev. Cancer,2009
2. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways;Takebe;Nat. Rev. Clin. Oncol.,2011
3. Targeting multidrug resistance in cancer;Szakacs;Nat. Rev. Drug Discov.,2006
4. Mechanisms of multidrug resistance in cancer treatment;Harris;Acta Oncol.,1992
5. Molecular and pharmacological strategies to overcome multidrug resistance;Shabbits;Expert Rev. Anticancer Ther.,2001
Cited by 215 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. pH-responsive degradable mesoporous organosilica nanoparticle for tumor targeting and phototherapy combined with chemotherapy;Journal of Drug Delivery Science and Technology;2024-02
2. Reversal mechanism of multidrug-resistant cancer cells by lectin as chemo-adjuvant and targeted therapy- a systematic review;Phytomedicine;2024-01
3. Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression;Biomaterials Science;2024
4. Nanomedicine Based Therapies Against Cancer Stem Cells;Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective;2023-12-27
5. Nitric Oxide‐Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment;Advanced Functional Materials;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3